CellWell record HH-526320
Prevention of Myc-Driven Prostate Cancer in Mice by Oral Administration of Sulforaphane
Krishna B Singh; Eun-Ryeong Hahm; Bruce L Jacobs; Shivendra V Singh
2026
In plain language
Oral sulforaphane reduced prostatic adenocarcinoma in situ incidence by about 54% in Hi-Myc mice, accompanied by suppressed fatty acid synthesis markers.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-526320
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.